INOVIO Pharmaceuticals

Name: INOVIO Pharmaceuticals
Address: 660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA, 19462, US
Telephone: +12674404200
Price range: $

Home
United States
Plymouth Meeting, PA
INOVIO Pharmaceuticals

INOVIO Pharmaceuticals, Inc.

INOVIO Pharmaceuticals Official page
We're trailblazers in the DNA medicine field, working to develop next-generation medicines to fight HPV-related disease, cancer and infectious disease. (INOVIO) is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer and HPV-associated diseases.

IN

OVIO’s DNA medicines platform and proprietary smart device can target virtually any DNA sequence. With 15 clinical programs currently in development, INOVIO has the potential to save and protect lives worldwide and power a new decade of DNA medicines.

For more information, visit www.inovio.com.

06/11/2026

DYK that is caused by strains 6 & 11 of the human papillomavirus (HPV)? So today – 6/11 – we’re spreading awareness about this debilitating rare disease and the urgent need for treatment options that can help every patient reduce their need for surgery. is proud to support the Recurrent Respiratory Papillomatosis Foundation in their efforts to amplify patient voices - because every surgery matters, every patient matters, and every patient deserves a treatment that works for them.

06/08/2026

See you at 2026! INOVIO will be there to highlight promising research on rare disease protein replacement therapeutics and the transformational potential of our next-gen DNA medicine technology.

05/28/2026

INOVIO is pleased to be participating in the upcoming 2026 Jefferies Global Healthcare Conference, where we’ll be discussing progress with lead candidate INO-3107 for and other highlights from our DNA medicine pipeline. Webcast available here: https://bit.ly/43Bk7e2

05/27/2026

INOVIO is pleased to be at this week to share additional data demonstrating how lead candidate INO-3107 for elicits a targeted immune response that is associated with improved clinical outcomes for patients. Read the abstract here: https://bit.ly/3PvCMop

05/21/2026

INOVIO’s partner ApolloBio announced positive topline results from a Phase 3 trial in China for VGX-3100 in patients with cervical dysplasia. The results further highlight the potential of to treat HPV-related diseases, eliminating or reducing the need for surgical interventions. Read more: https://bit.ly/4ukC3p2

05/14/2026

At our first quarter 2026 financial results call, CEO Dr. Jacqueline Shea reiterated INOVIO’s strategic focus on advancing lead candidate INO-3107 through the regulatory process and delivering on the promise of DNA medicine for RRP patients. To hear more on this and other corporate highlights, you can listen to the webcast replay here: https://bit.ly/4uIpVxW

05/13/2026

INOVIO reports financial results and operational highlights for the 1st quarter of 2026 – read more here: https://bit.ly/4nxmRm6

05/11/2026

INOVIO is excited to be at this week to highlight preclinical data from our next-gen DPROT technology for the treatment of Hemophilia A. Our research shows that DRPOTs have the potential to drive sustained production of complex proteins within the body and could be applicable to a wide range of rare protein-replacement diseases. Learn more about our next-gen technology here: https://inovio.com/dna-medicines-technology/

05/04/2026

It's , a month dedicated to raising awareness about brain tumors, their impact on patients, and the critical importance of research to improve brain tumor diagnosis and treatment. ’s focus: glioblastoma, the most common and aggressive form of brain cancer. According to the National Cancer Institute, about 15,000 people are diagnosed with glioblastoma each year and GBM patients are in desperate need of new treatment options to improve their prognosis. INOVIO is working with partners to develop innovative cancer immunotherapies to treat GBM that leverage the power of DNA medicine. Read more: bit.ly/4l8DvHr

Address

660 W. Germantown Pike, Suite 110
Plymouth Meeting, PA
19462

Telephone

+12674404200

Website

http://www.inovio.com/

Alerts

Be the first to know and let us send you an email when INOVIO Pharmaceuticals posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to INOVIO Pharmaceuticals:

Shortcuts

Want your business to be the top-listed Engineering Company in Plymouth Meeting?